Aristea Therapeutics Launches with Phase 2 Drug Candidate and $15M in Series A Funding from Novo Holdings A/S

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2BrYBuQ
via IFTTT